Reclast and Simponi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reclast (zoledronic acid) and Simponi (golimumab). Common drug interactions include hepatitis c among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Reclast and Simponi. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Reclast?

Reclast has active ingredients of zoledronic acid. It is often used in osteoporosis. eHealthMe is studying from 15,774 Reclast users. Check the latest studies of Reclast.

What is Simponi?

Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.



On Jul, 24, 2026

40 people who take Reclast and Simponi together, and have interactions are studied.

Reclast and Simponi drug interactions.

What are the common drug interactions of Reclast and Simponi, by gender? *:

female:

  1. Hepatitis c
  2. Swelling
  3. Urinary tract infection
  4. Abdominal pain upper
  5. Anxiety
  6. Balance disorder
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  9. Fall
  10. Herpes zoster

male:

  1. Insomnia (sleeplessness)
  2. Post procedural complication
  3. Procedural pain
  4. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  5. Drug effect decreased
  6. Drug ineffective
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Psoriasis (immune-mediated disease that affects the skin)

What are the common drug interactions of Reclast and Simponi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Insomnia (sleeplessness)
  2. Post procedural complication
  3. Procedural pain
  4. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  5. Drug effect decreased
  6. Drug ineffective
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Psoriasis (immune-mediated disease that affects the skin)

50-59:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Arthropathy
  3. Asthenia (weakness)
  4. Back pain
  5. Constipation
  6. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  7. Dizziness
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Epigastric discomfort

60+:

  1. Abdominal pain upper
  2. Balance disorder
  3. Furuncle (infection of the hair follicle)
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Influenza like illness
  7. Injection site reaction
  8. Insomnia (sleeplessness)
  9. Lung carcinoma cell type unspecified stage iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Pain: 6 people, 15.00%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 10.00%
  3. Seasonal Allergy (allergic condition due to certain season): 4 people, 10.00%
  4. High Blood Pressure: 4 people, 10.00%
  5. Diabetes: 4 people, 10.00%
  6. Overdose: 3 people, 7.50%
  7. Migraine Without Aura (headache without neurological problems): 2 people, 5.00%
  8. Joint Pain: 2 people, 5.00%
  9. Headache (pain in head): 2 people, 5.00%
  10. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Reclast and Simponi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reclast and Simponi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reclast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simponi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reclast and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simponi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on zoledronic acid and golimumab (the active ingredients of Reclast and Simponi, respectively), and Reclast and Simponi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: